UK markets close in 2 hours 51 minutes

FibroGen, Inc. (0IL8.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
52.55-0.14 (-0.26%)
As of 2:33PM GMT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 53.71B
Enterprise value 33.88B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)31.14
Price/book (mrq)10.57
Enterprise value/revenue 332.56
Enterprise value/EBITDA 6-18.26

Trading information

Stock price history

Beta (5Y monthly) 1.36
52-week change 3N/A
S&P500 52-week change 323.92%
52-week high 350.53
52-week low 349.36
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 584.98M
Float 84.48M
% held by insiders 17.91%
% held by institutions 176.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Sep 2020

Profitability

Profit margin -191.78%
Operating margin (ttm)-196.42%

Management effectiveness

Return on assets (ttm)-17.17%
Return on equity (ttm)-42.19%

Income statement

Revenue (ttm)119.29M
Revenue per share (ttm)1.34
Quarterly revenue growth (yoy)32.70%
Gross profit (ttm)46.16M
EBITDA -212.74M
Net income avi to common (ttm)-228.78M
Diluted EPS (ttm)-2.57
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)687.87M
Total cash per share (mrq)7.56
Total debt (mrq)61.1M
Total debt/equity (mrq)12.97
Current ratio (mrq)6.23
Book value per share (mrq)4.97

Cash flow statement

Operating cash flow (ttm)43.78M
Levered free cash flow (ttm)79.81M